Physician profile
Richard Chang
NPI 1275669954
$132,347.11
in general payments reported to CMS, 2019-2025
67 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $8,438 · 2020: $15K · 2021: $39K · 2022: $27K · 2023: $21K · 2024: $11K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $16K · Travel and Lodging: $2,563 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,268.75 |
| Food and Beverage | $15,865.48 |
| Travel and Lodging | $2,562.67 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $67,072.66 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $22,944.93 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Biotronik INC. | $11,154.97 | 2019-2025 | Selectra, Biomonitor, Amvia Edge |
| Abbott Laboratories | $6,370.53 | 2019-2025 | Amplatzer Amulet, Cardiomems, Amplatzer |
| Abiomed | $2,570.69 | 2019-2025 | Impella |
| Shockwave Medical, INC | $2,254.36 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $2,199.41 | 2019-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Impulse Dynamics (USA) INC. | $1,526.02 | 2022-2025 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,401.02 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $1,398.82 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $1,330.90 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $838.74 | 2019-2025 | Bodyguardian, Watchman Flx, Opticross |
| Actelion Pharmaceuticals US, INC. | $792.01 | 2022-2025 | Uptravi, Opsumit |
| Amgen INC. | $743.37 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $713.89 | 2019-2025 | Wainua, Farxiga |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $682.39 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $677.63 | 2019-2025 | |
| Medtronic Vascular, INC. | $635.69 | 2019 | |
| Altathera Pharmaceuticals LLC | $600.00 | 2022 | |
| Pfizer INC. | $530.39 | 2019-2025 | |
| Terumo Medical Corporation | $516.79 | 2021-2022 | |
| Amarin Pharma, INC. | $505.77 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $486.79 | 2020-2024 | Artis Icono Biplane |
| Merck Sharp & Dohme LLC | $468.24 | 2021-2025 | Verquvo, Winrevair |
| Esperion Therapeutics, INC. | $386.68 | 2020-2025 | Nexletol |
| Philips North America LLC | $364.20 | 2019-2025 | (5044) Mcot, Mcot, Igt Devices Systems Undivided |
| Sanofi-Aventis U.S. LLC | $310.44 | 2019-2024 | |
| Atricure, INC. | $298.02 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Cathworks, INC. | $219.98 | 2019-2022 | |
| Cvrx, INC. | $180.82 | 2021-2025 | Barostim Neo System |
| Medtronic, INC. | $162.87 | 2021-2024 | Ffrangio |
| Inari Medical, INC. | $155.35 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $144.98 | 2022-2024 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $120.96 | 2021-2025 | |
| Heartflow, INC. | $117.49 | 2019-2025 | Ffrct |
| Alnylam Pharmaceuticals INC. | $95.70 | 2022-2025 | Amvuttra |
| Lexicon Pharmaceuticals, INC. | $95.00 | 2024 | |
| Elutia, INC. | $91.51 | 2019 | |
| Cordis US Corp. | $85.84 | 2022 | |
| Cardiva Medical, INC. | $77.04 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Intuitive Surgical, INC. | $72.00 | 2024 | |
| Irhythm Technologies, INC. | $71.47 | 2019-2024 | Zio Xt Patch |
| Kiniksa Pharmaceuticals, LTD. | $70.94 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $67.84 | 2024 | Arcalyst |
| Corindus INC. | $64.98 | 2019 | |
| Bardy Diagnostics, INC. | $64.58 | 2021 | |
| Medela LLC | $59.87 | 2020 | |
| Teleflex LLC | $55.86 | 2022 | |
| Lundbeck LLC | $51.18 | 2019-2020 | |
| Baxter Healthcare | $50.48 | 2020-2023 | Hillrom - Cardiac Ambulatory Monitor |
| Braemar Manufacturing, LLC | $44.55 | 2019 | |
| Preventice Services, LLC | $42.34 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $40.48 | 2019-2021 | |
| Angiodynamics, INC. | $36.27 | 2021 | |
| Medicure Pharma INC. | $30.69 | 2021 | |
| Daiichi Sankyo INC. | $24.30 | 2023 | Injectafer |
| Penumbra, INC. | $22.74 | 2021 | |
| Reflow Medical INC | $21.02 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $19.82 | 2019 | |
| Agepha Pharma Fz LLC | $18.44 | 2025 | Lodoco |
| Scpharmaceuticals INC. | $17.85 | 2025 | |
| Bard Peripheral Vascular, INC. | $17.78 | 2019 | |
| Inspire Medical Systems, INC. | $17.72 | 2023 | Inspire |
| Octapharma USA, INC. | $15.52 | 2025 | Fibryga |
| Livanova USA, INC. | $13.59 | 2021 | |
| Davol INC. | $11.91 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$144,950.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.